NCT06827951 Potential Benefits of Parent Child Interaction Therapy (PCIT)
| NCT ID | NCT06827951 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Florida |
| Condition | Autonomic Dysregulation |
| Study Type | OBSERVATIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-02-14 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 80 participants in total. It began in 2025-02-14 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to explore possible benefits of Parent-Child Interaction Therapy (PCIT). The main goals of the study are: * To investigate whether pre-survey measures of autonomic reactivity relate to the overall functioning of participants. * To examine the effects of PCIT To identify individual characteristics that influence the effects of PCIT. Participants will: * complete 5 online surveys (1x pre-PCIT, 3x during PCIT, and 1x post-PCIT) * complete the PCIT program
Eligibility Criteria
Inclusion Criteria: * Parents of children aged 2-7 years old who are eligible for Parent-Child Interaction Therapy (PCIT) based on behavioral concerns. * The primary caregiver of the child and be actively involved in the child's daily care. * Willing to attend all PCIT sessions and complete pre-, mid- and post-intervention assessments. * Fluent in English to ensure comprehension of the intervention and assessment materials. Exclusion Criteria: * Parents with diagnosed severe mental health disorders (e.g., schizophrenia, bipolar disorder) that may interfere with participation in PCIT. * Children with conditions that require interventions other than PCIT (e.g., severe developmental disabilities). * Parents who have previously participated in PCIT are excluded to avoid confounding results.
Contact & Investigator
Britney N. Duner, LCSW
PRINCIPAL INVESTIGATOR
University of Florida College of Medicine Jacksonville
Frequently Asked Questions
Who can join the NCT06827951 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 89 Years, studying Autonomic Dysregulation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06827951 currently recruiting?
Yes, NCT06827951 is actively recruiting participants. Contact the research team at Britney.Duner@jax.ufl.edu for enrollment information.
Where is the NCT06827951 trial being conducted?
This trial is being conducted at Gainesville, United States, Jacksonville, United States.
Who is sponsoring the NCT06827951 clinical trial?
NCT06827951 is sponsored by University of Florida. The principal investigator is Britney N. Duner, LCSW at University of Florida College of Medicine Jacksonville. The trial plans to enroll 80 participants.